Systemic comorbidities in bronchiectasis

Chronic Respiratory Disease

Volumn 9, Issue 4, 2012, Pages 231-238

  Gale, Nichola S ^a,b   Bolton, Charlotte E ^a,c   Duckers, Jamie M ^a   Enright, Stephanie ^b   Cockcroft, John R ^a   Shale, Dennis J ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Arterial stiffness; body composition; bone mineral density; bronchiectasis; comorbidities

Indexed keywords

ALBUMIN; BRONCHODILATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; GLUCOSE; INTERLEUKIN 6;

ADULT; AGED; AIRWAY OBSTRUCTION; ALBUMIN BLOOD LEVEL; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; BONE DENSITY; BRONCHIECTASIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOSE BLOOD LEVEL; HAEMOPHILUS INFLUENZAE; HEART RATE; HUMAN; HYPERTENSION; LOBECTOMY; MALE; MEAN ARTERIAL PRESSURE; MUSCLE MASS; OSTEOPENIA; OSTEOPOROSIS; OXYGEN SATURATION; PERTUSSIS; PHYSICAL ACTIVITY; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSE WAVE; SELF CONCEPT; SKELETAL MUSCLE; SMOKING; STREPTOCOCCUS PNEUMONIAE;

AGED; AORTA; BLOOD PRESSURE; BODY MASS INDEX; BONE DENSITY; BRONCHIECTASIS; FEMALE; FIBROSIS; HUMANS; LIPIDS; MALE; MIDDLE AGED; MOTOR ACTIVITY; PULSE WAVE ANALYSIS; WALKING;

EID: 84868515587     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972312459973     Document Type: Article

References (30)

1. Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med. 2007 ; 101: 1163-1170
2. Ip M, Lauder I, Wong W, Lam W, So S. Multivariate analysis of factors affecting pulmonary function in bronchiectasis. Respiration. 1993 ; 60: 45-50
3. Roberts HR, Wells AU, Milne DG, Rubens MB, Kolbe J, Cole PJ, et al. Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax. 2000 ; 55: 198-204
4. Bolton CE, Ionescu A, Shiels K, Pettit R, Edwards P, Stone M, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004 ; 170: 1286-1293
5. Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD.. COPD and incident cardiovascular disease hospitalizations and mortality: kaiser permanente medical. Care Program Chest. 2005 ; 128: 2068-2075
6. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007 ; 175: 1259-1265
7. Duckers J, Shale D, Stockley R, Gale N, Evans B, Cockcroft J, et al. Cardiovascular and musculoskeletal co-morbidities in patients with alpha 1 antitrypsin deficiency. Respir Res. 2010 ; 11: 173
8. Hull JH, Garrod R, Ho TB, Knight RK, Cockcroft JR, Shale DJ, et al. Increased augmentation index in patients with cystic fibrosis. Eur Respir J. 2009 ; 34: 1322-1328
9. Ionescu AA, Evans WD, Pettit RJ, Nixon LS, Stone MD, Shale DJ. Hidden depletion of fat-free mass and bone mineral density in adults with cystic fibrosis. Chest. 2003 ; 124: 2220-2228
10. Onen ZP, Eris Gulbay B, Sen E, Akkoca Yildiz O, Saryal S, Acican T, et al. Analysis of the factors related to mortality in patients with bronchiectasis. Respir Med. 2007 ; 101: 1390-1397
11. Alzeer AH, Al-Mobeirek AF, Al-Otair HAK, Elzamzamy UAF, Joherjy IA, Shaffi AS. Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis. Chest. 2008 ; 133: 468-473
12. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005 ; 26: 319-338
13. WHO Scientific Group on the Prevention and Management of Osteoporosis; report of a WHO scientific group [WHO technical report series; 921]. http://whqlibdocwhoint/trs/WHO-TRS-921.pdf (2007). Accessed 20th April 2011.
14. Wilson P, Paffenbarger R. Morris JJ and Havlik R Assessment methods for physical activity and physical fitness in population studies: report of a NHLBI workshop. Am Heart J. 1986 ; 111: 1177-1192
15. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006 ; 27: 2588-2605
16. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British hypertension society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004 ; 328: 634-640
17. Hull JH, Garrod R, Ho TB, Knight RK, Cockcroft JR, Shale DJ, et al. Increased augmentation index in patients with cystic fibrosis. Eur Respir J. 2009 ; 34: 1322-1328
18. Haworth CS, Selby PL, Webb AK, Martin L, Elborn JS, Sharples LD, et al. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax. 2004 ; 59: 613-617
19. Swierblewska E, Hering D, Kara T, Kunicka K, Kruszewski P, Bieniaszewski L, et al. An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertens. 2010 ; 28: 979-984
20. Clapp BR, Hingorani AD, Kharbanda RK, Mohamed-Ali V, Stephens JW, Vallance P, et al. Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress. Cardiovasc Res. 2004 ; 64: 172-178
21. Pannier B, Guerin AP, Marchais SJ. Safar ME and London GM Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension. 2005 ; 45: 592-596
22. Sin DD. Wu L and Man SFP The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005 ; 127: 1952-1959
23. Zureik M, Benetos A, Neukirch C, Courbon D, Bean K, Thomas F, et al. Reduced pulmonary function is associated with central arterial stiffness in men. Am J Respir Crit Care Med. 2001 ; 164: 2181-2185
24. Cesari M, Penninx BWJH, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K, et al. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am J Cardiol. 2003 ; 92: 522-528
25. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005 ; 112: 2193-2200
26. Guran T, Turan S, Karadag B, Ersu R, Karakoc F, Bereket A, et al. Bone mineral density in children with non-cystic fibrosis bronchiectasis. Respiration. 2008 ; 75: 432-436
27. Ip M, Lam WK, Chan JC, Liong E. Systemic effects of inflammation in bronchiectasis. Respir Med. 1991 ; 85: 521-525
28. Maggi S, Siviero P, Gonnelli S, Schiraldi C, Malavolta N, Nuti R, et al. Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study. J Clin Densitom. 2009 ; 12: 345-352
29. Koulouris NG, Retsou S, Kosmas E, Dimakou K, Malagari K, Mantzikopoulos G, et al. Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J. 2003 ; 21: 743-748
30. Lee AL, Button BM, Ellis S, Stirling R, Wilson JW, Holland AE, et al. Clinical determinants of the 6-minute walk test in bronchiectasis. Respir Med. 2009 ; 103: 780-785